Research And Development Expense of AC Immune SA from 31 Dec 2015 to 30 Jun 2024

Taxonomy & unit
ifrs-full: CHF
Summary
AC Immune SA quarterly and annual Research And Development Expense in CHF history and change rate from 31 Dec 2015 to 30 Jun 2024.
  • AC Immune SA Research And Development Expense for the quarter ending 30 Jun 2024 was CHF17,138,000, a 25% increase year-over-year.
  • AC Immune SA annual Research And Development Expense for 2023 was CHF54,606,000, a 9.5% decline from 2022.
  • AC Immune SA annual Research And Development Expense for 2022 was CHF60,336,000, a 3.1% decline from 2021.
  • AC Immune SA annual Research And Development Expense for 2021 was CHF62,282,000, a 4.7% increase from 2020.
Source SEC data
View on sec.gov
Research And Development Expense, Trailing 12 Months (CHF)
Research And Development Expense, Quarterly (CHF)
Research And Development Expense, YoY Quarterly Change (%)
Research And Development Expense, Annual (CHF)
Research And Development Expense, YoY Annual Change (%)

AC Immune SA Quarterly Research And Development Expense (CHF)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 CHF17,138,000 +CHF3,456,000 +25% 01 Apr 2024 30 Jun 2024 6-K 06 Aug 2024 2024 Q2
Q2 2023 CHF13,682,000 -CHF2,010,000 -13% 01 Apr 2023 30 Jun 2023 6-K 06 Aug 2024 2024 Q2
Q3 2022 CHF14,385,000 -CHF733,000 -4.8% 01 Jul 2022 30 Sep 2022 6-K 28 Oct 2022 2022 Q3
Q2 2022 CHF15,692,000 01 Apr 2022 30 Jun 2022 6-K 04 Aug 2023 2023 Q2
Q3 2021 CHF15,118,000 01 Jul 2021 30 Sep 2021 6-K 28 Oct 2022 2022 Q3
Q4 2018 CHF44,277,000 CHF12,129,000 +CHF1,953,000 +19% 01 Oct 2018 31 Dec 2018 20-F 21 Mar 2019 2018 FY
Q3 2018 CHF42,324,000 CHF11,546,000 +CHF3,351,000 +41% 01 Jul 2018 30 Sep 2018 20-F 21 Mar 2019 2018 FY
Q2 2018 CHF38,973,000 CHF10,533,000 +CHF3,695,000 +54% 01 Apr 2018 30 Jun 2018 20-F 21 Mar 2019 2018 FY
Q1 2018 CHF35,278,000 CHF10,069,000 +CHF2,615,000 +35% 01 Jan 2018 31 Mar 2018 20-F 21 Mar 2019 2018 FY
Q4 2017 CHF32,663,000 CHF10,176,000 01 Oct 2017 31 Dec 2017 20-F 21 Mar 2019 2018 FY
Q3 2017 CHF8,195,000 01 Jul 2017 30 Sep 2017 20-F 21 Mar 2019 2018 FY
Q2 2017 CHF6,838,000 01 Apr 2017 30 Jun 2017 20-F 21 Mar 2019 2018 FY
Q1 2017 CHF7,454,000 01 Jan 2017 31 Mar 2017 20-F 21 Mar 2019 2018 FY

AC Immune SA Annual Research And Development Expense (CHF)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 CHF54,606,000 -CHF5,730,000 -9.5% 01 Jan 2023 31 Dec 2023 20-F 14 Mar 2024 2023 FY
2022 CHF60,336,000 -CHF1,946,000 -3.1% 01 Jan 2022 31 Dec 2022 20-F 14 Mar 2024 2023 FY
2021 CHF62,282,000 +CHF2,795,000 +4.7% 01 Jan 2021 31 Dec 2021 20-F 14 Mar 2024 2023 FY
2020 CHF59,487,000 +CHF9,055,000 +18% 01 Jan 2020 31 Dec 2020 20-F 16 Mar 2023 2022 FY
2019 CHF50,432,000 +CHF6,155,000 +14% 01 Jan 2019 31 Dec 2019 20-F 22 Mar 2022 2021 FY
2018 CHF44,277,000 +CHF11,614,000 +36% 01 Jan 2018 31 Dec 2018 20-F 23 Mar 2021 2020 FY
2017 CHF32,663,000 +CHF6,889,000 +27% 01 Jan 2017 31 Dec 2017 20-F 30 Mar 2020 2019 FY
2016 CHF25,774,000 +CHF8,725,000 +51% 01 Jan 2016 31 Dec 2016 20-F 21 Mar 2019 2018 FY
2015 CHF17,049,000 01 Jan 2015 31 Dec 2015 20-F 20 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.